Palladium Nanoplate-Based IL-6 Receptor Antagonists Ameliorate Cancer-Related Anemia and Simultaneously Inhibit Cancer Progression
Abstract
Research context
OpenAlex topics: Erythropoietin and Anemia Treatment · Phagocytosis and Immune Regulation · PARP inhibition in cancer therapy
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China
Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China
University of Chinese Academy of Sciences, Beijing 100049, China
Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California 90095, United States
Funding
Young Elite Scientists Sponsorship Program by Tianjin · National Natural Science Foundation of China · Tianjin Education Commission for Higher Education · Tianjin Research Program of Application Foundation and Advanced Technology